SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950170-24-030848
Filing Date
2024-03-13
Accepted
2024-03-13 16:52:08
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 crbp_s-3_2024_03_13.htm S-3 799501
2 EX-4.5 crbp-ex4_5.htm EX-4.5 557331
3 EX-4.6 crbp-ex4_6.htm EX-4.6 575750
4 EX-5.1 crbp-ex5_1.htm EX-5.1 30099
5 EX-23.1 crbp-ex23_1.htm EX-23.1 5130
6 EX-FILING FEES crbp-exfiling_fees.htm EX-FILING FEES 81263
7 GRAPHIC img147854343_0.jpg GRAPHIC 3525
8 GRAPHIC img147854343_1.jpg GRAPHIC 3525
9 GRAPHIC img147854343_2.jpg GRAPHIC 3525
10 GRAPHIC img147854343_3.jpg GRAPHIC 2196
  Complete submission text file 0000950170-24-030848.txt   2068350
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-277888 | Film No.: 24746701
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)